Focused on Results, Dedicated to Innovation
Launched on January 1, 2013, AbbVie is a global biopharmaceutical company with focus and capabilities to address some of the world’s greatest health challenges. AbbVie discovers, develops, and commercializes advanced therapies that have an impact on people’s lives. Today, our passionate AbbVie team has approximately 21,000 employees working together to help patients around the world. Headquartered in North Chicago, Illinois, AbbVie has seven research and development and manufacturing facilities worldwide.
The principal market for AbbVie’s common shares is the New York Stock Exchange. Shares are also listed on the Chicago Stock Exchange and traded on various regional and electronic exchanges. Outside the United States, AbbVie’s shares are listed on the NYSE Euronext Paris, and the SIX Swiss Exchange.
VIEW MORE »| There are currently no events scheduled. |
|
AbbVie’s presentation at the Cowen Healthcare Conference on March 6, 2013 has been cancelled due to weather.
FAST FACTS
21,000Approximate Number of Global Employees
170+Countries Where Products are Sold
